The link between glycemic control measures and eye microvascular complications in a clinical cohort of type 2 diabetes with microRNA-223-3p signature
<h3>Background</h3><p dir="ltr">Type 2 diabetes (T2D) is a critical healthcare challenge and priority in Qatar which is listed amongst the top 10 countries in the world, with its prevalence presently at 17% double the global average. MicroRNAs (miRNAs) are implicated in t...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , , , , , , |
| منشور في: |
2023
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513526859563008 |
|---|---|
| author | Sahar I. Da’as (9631717) |
| author2 | Ikhlak Ahmed (150200) Waseem H. Hasan (15273008) Doua A. Abdelrahman (15273011) Elbay Aliyev (14056972) Sabah Nisar (12561961) Ajaz Ahmad Bhat (12561955) Mugdha V. Joglekar (5914709) Anandwardhan A. Hardikar (7628087) Khalid A. Fakhro (3158862) Ammira S. Al-Shabeeb Akil (15376391) |
| author2_role | author author author author author author author author author author |
| author_facet | Sahar I. Da’as (9631717) Ikhlak Ahmed (150200) Waseem H. Hasan (15273008) Doua A. Abdelrahman (15273011) Elbay Aliyev (14056972) Sabah Nisar (12561961) Ajaz Ahmad Bhat (12561955) Mugdha V. Joglekar (5914709) Anandwardhan A. Hardikar (7628087) Khalid A. Fakhro (3158862) Ammira S. Al-Shabeeb Akil (15376391) |
| author_role | author |
| dc.creator.none.fl_str_mv | Sahar I. Da’as (9631717) Ikhlak Ahmed (150200) Waseem H. Hasan (15273008) Doua A. Abdelrahman (15273011) Elbay Aliyev (14056972) Sabah Nisar (12561961) Ajaz Ahmad Bhat (12561955) Mugdha V. Joglekar (5914709) Anandwardhan A. Hardikar (7628087) Khalid A. Fakhro (3158862) Ammira S. Al-Shabeeb Akil (15376391) |
| dc.date.none.fl_str_mv | 2023-03-03T03:00:00Z |
| dc.identifier.none.fl_str_mv | 10.1186/s12967-023-03893-2 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/The_link_between_glycemic_control_measures_and_eye_microvascular_complications_in_a_clinical_cohort_of_type_2_diabetes_with_microRNA-223-3p_signature/25256692 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biological sciences Biochemistry and cell biology Genetics Type 2 diabetes Diabetic retinopathy miR-223-3p Zebrafsh modeling Hyperglycemia Functional validation |
| dc.title.none.fl_str_mv | The link between glycemic control measures and eye microvascular complications in a clinical cohort of type 2 diabetes with microRNA-223-3p signature |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <h3>Background</h3><p dir="ltr">Type 2 diabetes (T2D) is a critical healthcare challenge and priority in Qatar which is listed amongst the top 10 countries in the world, with its prevalence presently at 17% double the global average. MicroRNAs (miRNAs) are implicated in the pathogenesis of (T2D) and long-term microvascular complications including diabetic retinopathy (DR).</p><h3>Methods</h3><p dir="ltr">In this study, a T2D cohort that accurately matches the characteristics of the general population was employed to find microRNA (miRNA) signatures that are correlated with glycemic and β cell function measurements. Targeted miRNA profiling was performed in (471) T2D individuals with or without DR and (491) (non-diabetic) healthy controls from the Qatar Biobank. Discovery analysis identified 20 differentially expressed miRNAs in T2D compared to controls, of which miR-223-3p was significantly upregulated (fold change:5.16, p = 3.6e−02) and positively correlated with glucose and hemoglobin A1c (HbA1c) levels (p-value = 9.88e−04 and 1.64e−05, respectively), but did not show any significant associations with insulin or C-peptide. Accordingly, we performed functional validation using a miR-223-3p mimic (overexpression) under control and hyperglycemia-induced conditions in a zebrafish model.</p><h3>Results</h3><p dir="ltr">Over-expression of miR-223-3p alone was associated with significantly higher glucose (42.7 mg/dL, n = 75 vs 38.7 mg/dL, n = 75, p = 0.02) and degenerated retinal vasculature, and altered retinal morphology involving changes in the ganglion cell layer and inner and outer nuclear layers. Assessment of retinal angiogenesis revealed significant upregulation in the expression of vascular endothelial growth factor and its receptors, including kinase insert domain receptor. Further, the pancreatic markers, pancreatic and duodenal homeobox 1, and the insulin gene expressions were upregulated in the miR-223-3p group.</p><h3>Conclusion</h3><p dir="ltr">Our zebrafish model validates a novel correlation between miR-223-3p and DR development. Targeting miR-223-3p in T2D patients may serve as a promising therapeutic strategy to control DR in at-risk individuals.</p><h2>Other Information</h2><p dir="ltr">Published in: Journal of Translational Medicine<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1186/s12967-023-03893-2" target="_blank">https://dx.doi.org/10.1186/s12967-023-03893-2</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_f846342339a3c951a3a79c0ee9e10733 |
| identifier_str_mv | 10.1186/s12967-023-03893-2 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/25256692 |
| publishDate | 2023 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | The link between glycemic control measures and eye microvascular complications in a clinical cohort of type 2 diabetes with microRNA-223-3p signatureSahar I. Da’as (9631717)Ikhlak Ahmed (150200)Waseem H. Hasan (15273008)Doua A. Abdelrahman (15273011)Elbay Aliyev (14056972)Sabah Nisar (12561961)Ajaz Ahmad Bhat (12561955)Mugdha V. Joglekar (5914709)Anandwardhan A. Hardikar (7628087)Khalid A. Fakhro (3158862)Ammira S. Al-Shabeeb Akil (15376391)Biological sciencesBiochemistry and cell biologyGeneticsType 2 diabetesDiabetic retinopathymiR-223-3pZebrafsh modelingHyperglycemiaFunctional validation<h3>Background</h3><p dir="ltr">Type 2 diabetes (T2D) is a critical healthcare challenge and priority in Qatar which is listed amongst the top 10 countries in the world, with its prevalence presently at 17% double the global average. MicroRNAs (miRNAs) are implicated in the pathogenesis of (T2D) and long-term microvascular complications including diabetic retinopathy (DR).</p><h3>Methods</h3><p dir="ltr">In this study, a T2D cohort that accurately matches the characteristics of the general population was employed to find microRNA (miRNA) signatures that are correlated with glycemic and β cell function measurements. Targeted miRNA profiling was performed in (471) T2D individuals with or without DR and (491) (non-diabetic) healthy controls from the Qatar Biobank. Discovery analysis identified 20 differentially expressed miRNAs in T2D compared to controls, of which miR-223-3p was significantly upregulated (fold change:5.16, p = 3.6e−02) and positively correlated with glucose and hemoglobin A1c (HbA1c) levels (p-value = 9.88e−04 and 1.64e−05, respectively), but did not show any significant associations with insulin or C-peptide. Accordingly, we performed functional validation using a miR-223-3p mimic (overexpression) under control and hyperglycemia-induced conditions in a zebrafish model.</p><h3>Results</h3><p dir="ltr">Over-expression of miR-223-3p alone was associated with significantly higher glucose (42.7 mg/dL, n = 75 vs 38.7 mg/dL, n = 75, p = 0.02) and degenerated retinal vasculature, and altered retinal morphology involving changes in the ganglion cell layer and inner and outer nuclear layers. Assessment of retinal angiogenesis revealed significant upregulation in the expression of vascular endothelial growth factor and its receptors, including kinase insert domain receptor. Further, the pancreatic markers, pancreatic and duodenal homeobox 1, and the insulin gene expressions were upregulated in the miR-223-3p group.</p><h3>Conclusion</h3><p dir="ltr">Our zebrafish model validates a novel correlation between miR-223-3p and DR development. Targeting miR-223-3p in T2D patients may serve as a promising therapeutic strategy to control DR in at-risk individuals.</p><h2>Other Information</h2><p dir="ltr">Published in: Journal of Translational Medicine<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1186/s12967-023-03893-2" target="_blank">https://dx.doi.org/10.1186/s12967-023-03893-2</a></p>2023-03-03T03:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1186/s12967-023-03893-2https://figshare.com/articles/journal_contribution/The_link_between_glycemic_control_measures_and_eye_microvascular_complications_in_a_clinical_cohort_of_type_2_diabetes_with_microRNA-223-3p_signature/25256692CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/252566922023-03-03T03:00:00Z |
| spellingShingle | The link between glycemic control measures and eye microvascular complications in a clinical cohort of type 2 diabetes with microRNA-223-3p signature Sahar I. Da’as (9631717) Biological sciences Biochemistry and cell biology Genetics Type 2 diabetes Diabetic retinopathy miR-223-3p Zebrafsh modeling Hyperglycemia Functional validation |
| status_str | publishedVersion |
| title | The link between glycemic control measures and eye microvascular complications in a clinical cohort of type 2 diabetes with microRNA-223-3p signature |
| title_full | The link between glycemic control measures and eye microvascular complications in a clinical cohort of type 2 diabetes with microRNA-223-3p signature |
| title_fullStr | The link between glycemic control measures and eye microvascular complications in a clinical cohort of type 2 diabetes with microRNA-223-3p signature |
| title_full_unstemmed | The link between glycemic control measures and eye microvascular complications in a clinical cohort of type 2 diabetes with microRNA-223-3p signature |
| title_short | The link between glycemic control measures and eye microvascular complications in a clinical cohort of type 2 diabetes with microRNA-223-3p signature |
| title_sort | The link between glycemic control measures and eye microvascular complications in a clinical cohort of type 2 diabetes with microRNA-223-3p signature |
| topic | Biological sciences Biochemistry and cell biology Genetics Type 2 diabetes Diabetic retinopathy miR-223-3p Zebrafsh modeling Hyperglycemia Functional validation |